Cargando…
A Review of HER4 (ErbB4) Kinase, Its Impact on Cancer, and Its Inhibitors
HER4 is a receptor tyrosine kinase that is required for the evolution of normal body systems such as cardiovascular, nervous, and endocrine systems, especially the mammary glands. It is activated through ligand binding and activates MAPKs and PI3K/AKT pathways. HER4 is commonly expressed in many hum...
Autores principales: | El-Gamal, Mohammed I., Mewafi, Nada H., Abdelmotteleb, Nada E., Emara, Minnatullah A., Tarazi, Hamadeh, Sbenati, Rawan M., Madkour, Moustafa M., Zaraei, Seyed-Omar, Shahin, Afnan I., Anbar, Hanan S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8659013/ https://www.ncbi.nlm.nih.gov/pubmed/34885957 http://dx.doi.org/10.3390/molecules26237376 |
Ejemplares similares
-
Evaluation of Substituted Pyrazole-Based Kinase Inhibitors in One Decade (2011–2020): Current Status and Future Prospects
por: El-Gamal, Mohammed I., et al.
Publicado: (2022) -
Endocrine resistance in breast cancer: new roles for ErbB3 and ErbB4
por: Sutherland, Robert L
Publicado: (2011) -
c-erbB-4 protein expression in human breast cancer
por: Kew, T Y, et al.
Publicado: (2000) -
Proteolytic Processing of ErbB4 in Breast Cancer
por: Hollmén, Maija, et al.
Publicado: (2012) -
Novel Anti-Acanthamoebic Activities of Irosustat and STX140 and Their Nanoformulations
por: Siddiqui, Ruqaiyyah, et al.
Publicado: (2023)